PT724600E - Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido - Google Patents

Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido

Info

Publication number
PT724600E
PT724600E PT94931070T PT94931070T PT724600E PT 724600 E PT724600 E PT 724600E PT 94931070 T PT94931070 T PT 94931070T PT 94931070 T PT94931070 T PT 94931070T PT 724600 E PT724600 E PT 724600E
Authority
PT
Portugal
Prior art keywords
pct
alpha
inter
trypsin inhibitor
preparing
Prior art date
Application number
PT94931070T
Other languages
English (en)
Inventor
Catherine Michalski
Jacques Mizon
Original Assignee
Assoc Pour L Essor La T Sang D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assoc Pour L Essor La T Sang D filed Critical Assoc Pour L Essor La T Sang D
Publication of PT724600E publication Critical patent/PT724600E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT94931070T 1993-10-18 1994-10-17 Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido PT724600E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9312346A FR2711371B1 (fr) 1993-10-18 1993-10-18 Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.

Publications (1)

Publication Number Publication Date
PT724600E true PT724600E (pt) 2002-07-31

Family

ID=9451908

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94931070T PT724600E (pt) 1993-10-18 1994-10-17 Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido

Country Status (12)

Country Link
US (1) US5777081A (pt)
EP (1) EP0724600B1 (pt)
JP (1) JP3650937B2 (pt)
AT (1) ATE213252T1 (pt)
AU (1) AU7996294A (pt)
CA (1) CA2174231C (pt)
DE (1) DE69429868T2 (pt)
DK (1) DK0724600T3 (pt)
ES (1) ES2173927T3 (pt)
FR (1) FR2711371B1 (pt)
PT (1) PT724600E (pt)
WO (1) WO1995011260A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3626982B2 (ja) * 1997-08-29 2005-03-09 アークレイ株式会社 タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット
US6596705B1 (en) 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
US6660482B1 (en) 2000-02-28 2003-12-09 Rhode Island Hospital Inter-alpha-trypsin inhibitor as a marker for sepsis
AU2002216968A1 (en) * 2000-10-13 2002-04-22 Octapharma Ag Plasma fraction containing bikunin, method for the production thereof and use of the same
EP1542704A1 (en) * 2002-04-18 2005-06-22 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
USRE47972E1 (en) 2003-11-08 2020-05-05 Prothera Biologics, Inc. Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
ES2673005T3 (es) * 2008-05-28 2018-06-19 Prothera Biologics, Inc Preparación y composición de proteínas inter-alfa inhibidoras a partir de sangre
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
MX2013000958A (es) * 2010-07-23 2013-11-20 Baxter Healthcare Sa Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
US9572872B2 (en) 2012-09-09 2017-02-21 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
CN103880951B (zh) * 2014-03-31 2016-03-30 南昌市万华生化制品有限公司 一种通过乌司他丁亲和层析介质制备纯品乌司他丁的方法
EP3362464B1 (en) * 2015-10-15 2021-04-28 Plasma Technologies LLC Methods for extracting proteins from blood plasma
CN109776674B (zh) * 2019-02-19 2020-01-17 广东天普生化医药股份有限公司 纯化的乌司他丁及其制备方法和含有该乌司他丁的药物组合物
TW202142562A (zh) 2020-03-05 2021-11-16 美商迪亞醫藥美國公司 烏司他丁多肽

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1434199A (fr) * 1964-01-10 1966-04-08 Behringwerke Ag Procédé d'isolement d'inhibiteurs de la plasmine et de la trypsine à partir de liquides organiques d'origine humaine ou animale
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
US5445958A (en) * 1987-12-22 1995-08-29 National Blood Authority Process for purifying blood clotting factors

Also Published As

Publication number Publication date
DE69429868T2 (de) 2002-09-19
WO1995011260A1 (fr) 1995-04-27
CA2174231C (fr) 2004-06-01
CA2174231A1 (fr) 1995-04-27
ATE213252T1 (de) 2002-02-15
EP0724600A1 (fr) 1996-08-07
JP3650937B2 (ja) 2005-05-25
DE69429868D1 (de) 2002-03-21
JPH09503775A (ja) 1997-04-15
FR2711371B1 (fr) 1995-12-29
US5777081A (en) 1998-07-07
DK0724600T3 (da) 2002-05-27
AU7996294A (en) 1995-05-08
EP0724600B1 (fr) 2002-02-13
ES2173927T3 (es) 2002-11-01
FR2711371A1 (fr) 1995-04-28

Similar Documents

Publication Publication Date Title
PT724600E (pt) Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido
AU7002394A (en) Immunoglobulin g concentrate for therapeutical use and method for producing same
DK1571208T3 (da) Fremgangsmåde til ny faktor IX-rensning
ATE135908T1 (de) Optisch reines r(-)albuterol zur behandlung von asthma
BR9506667A (pt) Composto intermediário de cloro-pirimidina processo para a preparação do composto intermediário de cloro-pirimidina processo para a preparação de 2,5-diamino-4,6-dicloro-pirimidina processo para a preparação de 2,6-diamino-purinas e processo para a preparação de (1s,4s)-4-2-amino-6-(ciclo-propil-amino)-9h-purin-9-il¾-2-ciclo-penteno-1-metanol
DK0630228T3 (da) Middel til regulering af hudens fedtethed
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
BR9812837A (pt) Processo para fazer um composto, e, composto
FI102177B1 (fi) Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet
BG102064A (en) Method for increasing the retinal blood circulation
AU633925B2 (en) Process for the preparation of purified albumin solutions
DK0656209T3 (da) Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser
AU4876196A (en) A process for the preparation of factor ix from biological sources
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
ES2138734T3 (es) Procedimiento para la preparacion de derivados de 1-(3-trialquilsililfenil)-2,2,2-trifluormetil etanona.
ITRM940071A0 (it) Proedimento per la riconcia delle pelli conciate.
AU7942794A (en) Process for the preparation of an oxirane, aziridine or cyclopropane
ES2147601T3 (es) Procedimiento para la preparacion de 3-amino-2-cloro-4-alquil-piridinas o 3-amino-2-cloro-4-cicloalquil-piridinas.
RU93035807A (ru) Способ лечения юношеского эпифизиолиса
PT92863A (pt) Purificacao num so passo de glicerol oxidase de origem microbiana
FR2702213B1 (fr) Procédé de préparation de N-méthyl (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxyde-1-(1R,2R).
ITMI972528A1 (it) Processo per la preparazione e purificazione di cis-1, 3-dioxa-2-fenil -5-esanolo
AU6661394A (en) Purification of fluoronucleosides